Validation of the IMPROVE‐DD risk assessment model for venous thromboembolism among hospitalized patients with COVID‐19

BACKGROUND: Antithrombotic guidance statements for hospitalized patients with coronavirus disease 2019 (COVID‐19) suggest a universal thromboprophylactic strategy with potential to escalate doses in high‐risk patients. To date, no clear approach exists to discriminate patients at high risk for venou...

Descripción completa

Detalles Bibliográficos
Autores principales: Spyropoulos, Alex C., Cohen, Stuart L., Gianos, Eugenia, Kohn, Nina, Giannis, Dimitrios, Chatterjee, Saurav, Goldin, Mark, Lesser, Marty, Coppa, Kevin, Hirsch, Jamie S., McGinn, Thomas, Barish, Matthew A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles ‐ Thrombosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938615/
https://www.ncbi.nlm.nih.gov/pubmed/33733028
http://dx.doi.org/10.1002/rth2.12486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938615/
https://www.ncbi.nlm.nih.gov/pubmed/33733028
http://dx.doi.org/10.1002/rth2.12486

Ejemplares similares